Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hecht

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Antimicrobial Agents and Chemotherapy|September 18, 2002
In vitro activities of newer quinolones against bacteroides group organismsD R Snydman, N V Jacobus, L A McDermott, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996D R Snydman, N V Jacobus, L A McDermott, et al.
The Journal of Antimicrobial Chemotherapy|October 5, 2015
Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infectionD N Gerding, D W Hecht, T Louie, et al.
Anaerobe|June 14, 2011
Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009D R Snydman, N V Jacobus, L A McDermott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2002
National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000D R Snydman, N V Jacobus, L A McDermott, et al.
The Journal of Antimicrobial Chemotherapy|July 17, 2003
Emergence of fluoroquinolone resistance among Bacteroides speciesYoav Golan, Laura A McDermott, Nilda V Jacobus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1996
Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994D R Snydman, L McDermott, G J Cuchural, et al.
Anaerobe|November 7, 2016
Changes in the antibiotic susceptibility of anaerobic bacteria from 2007-2009 to 2010-2012 based on the CLSI methodologyChristine J Hastey, Halsey Boyd, Audrey N Schuetz, et al.
Antimicrobial Agents and Chemotherapy|February 7, 2007
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004D R Snydman, N V Jacobus, L A McDermott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2010
Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007)David R Snydman, Nilda V Jacobus, Laura A McDermott, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Antimicrobial Agents and Chemotherapy|September 18, 2002
In vitro activities of newer quinolones against bacteroides group organismsD R Snydman, N V Jacobus, L A McDermott, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996D R Snydman, N V Jacobus, L A McDermott, et al.
The Journal of Antimicrobial Chemotherapy|October 5, 2015
Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infectionD N Gerding, D W Hecht, T Louie, et al.
Anaerobe|June 14, 2011
Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009D R Snydman, N V Jacobus, L A McDermott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2002
National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000D R Snydman, N V Jacobus, L A McDermott, et al.
The Journal of Antimicrobial Chemotherapy|July 17, 2003
Emergence of fluoroquinolone resistance among Bacteroides speciesYoav Golan, Laura A McDermott, Nilda V Jacobus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1996
Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994D R Snydman, L McDermott, G J Cuchural, et al.
Anaerobe|November 7, 2016
Changes in the antibiotic susceptibility of anaerobic bacteria from 2007-2009 to 2010-2012 based on the CLSI methodologyChristine J Hastey, Halsey Boyd, Audrey N Schuetz, et al.
Antimicrobial Agents and Chemotherapy|February 7, 2007
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004D R Snydman, N V Jacobus, L A McDermott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2010
Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007)David R Snydman, Nilda V Jacobus, Laura A McDermott, et al.
Pageof 10